Targeting M-Calpain for Therapeutic Applications (P5768)

Target Name: m-Calpain

NCBI ID: P5768

Other Name(s): Calpain-2

Targeting M-Calpain for Therapeutic Applications

M-Calpain (Calpain-2) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a key regulator of pain signaling and has been implicated in a number of diseases, including chronic pain, neurodegenerative diseases, and cancer.

Recent studies have suggested that M-Calpain (Calpain-2) may be a drug target (or biomarker) for a number of potential therapeutic approaches. One approach is to target M-Calpain (Calpain-2) directly with small molecules, such as drugs that can inhibit its activity or enhance its sensitivity to inhibitors. Another approach is to target M-Calpain (Calpain-2) through its downstream signaling pathways, such as the PI3K/Akt pathway.

Targeting M-Calpain (Calpain-2) has the potential to treat a wide range of conditions, including chronic pain, neurodegenerative diseases, and cancer. For example, M-Calpain (Calpain-2) has been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been implicated in the development and progression of certain types of cancer, such as breast and ovarian cancer.

In addition to its potential therapeutic applications, M-Calpain (Calpain-2) is also a valuable research tool for studying the underlying mechanisms of pain and other biological processes. By studying the behavior of M-Calpain (Calpain-2), researchers can gain insights into how pain is generated and how it can be treated. This knowledge can inform the development of new therapeutic approaches for a variety of conditions.

Overall, M-Calpain (Calpain-2) is a protein that holds great promise as a drug target (or biomarker) for the treatment of a wide range of conditions. Further research is needed to fully understand its role in pain and other biological processes, and to develop effective therapies based on its targeting.

Protein Name: M-Calpain

More Common Targets